Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma

British Journal of Haematology

Volumn 140, Issue 3, 2008, Pages 287-294

  Kim, Hee Nam ^a   Lee, Il Kwon ^a   Kim, Yeo Kyeoung ^a   Tran, Huong Thi Thanh ^a   Yang, Deok Hwan ^a   Lee, Je Jung ^a   Shin, Min Ho ^b   Park, Kyeong Soo ^c   Shin, Myung Geun ^a   Choi, Jin Su ^b   Kim, Hyeoung Joon ^a  

^a Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Seonam University   (South Korea)

Author keywords

Methionine synthase reductase; Methylenetetrahydrofolate reductase; Non Hodgkin lymphoma; Polymorphism; Thymidylate synthase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; METHIONINE SYNTHASE REDUCTASE; THYMIDYLATE SYNTHASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MTHFR 677CT GENE; MTHFR 677TT GENE; MTHFR GENE; NONHODGKIN LYMPHOMA; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; THYMIDYLATE SYNTHASE;

EID: 38349116219     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06893.x     Document Type: Article

References (39)

1. Banerjee, R.V. Matthews, R.G. (1990) Cobalamin-dependent methionine synthase. FASEB Journal, 4, 1450 1459.
2. Chen, J., Giovannucci, E., Kelsey, K., Rimm, E.B., Stampfer, M.J., Colditz, G.A., Spiegelman, D., Willett, W.C. Hunter, D.J. (1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Research, 56, 4862 4864.
3. Chu, J. Dolnick, B.J. (2002) Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA. Biochimica et Biophysica Acta, 1587, 183 193.
4. Esteller, M., Garcia, A., Martinez-Palones, J.M., Xercavins, J. Reventos, J. (1997) Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis, 18, 2307 2311.
5. Feix, A., Fritsche-Polanz, R., Kletzmayr, J., Vychytil, A., Horl, W.H., Sunder-Plassmann, G. Fodinger, M. (2001) Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels. American Journal of Kidney Diseases, 38, 956 964.
6. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J., den Heijer, M., Kluijtmans, L.A., van den Heuvel, L.P. Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111 113.
7. Gaughan, D.J., Kluijtmans, L.A., Barbaux, S., McMaster, D., Young, I.S., Yarnell, J.W., Evans, A. Whitehead, A.S. (2001) The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis, 157, 451 456.
8. Gemmati, D., Ongaro, A., Scapoli, G.L., Della Porta, M., Tognazzo, S., Serino, M.L., Di Bona, E., Rodeghiero, F., Gilli, G., Reverberi, R., Caruso, A., Pasello, M., Pellati, A. De Mattei, M. (2004) Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiology, Biomarkers and Prevention, 13, 787 794.
9. Hishida, A., Matsuo, K., Hamajima, N., Ito, H., Ogura, M., Kagami, Y., Taji, H., Morishima, Y., Emi, N. Tajima, K. (2003) Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica, 88, 159 166.
10. Hori, T., Ayusawa, D., Shimizu, K., Koyama, H. Seno, T. (1984) Chromosome breakage induced by thymidylate stress in thymidylate synthase-negative mutants of mouse FM3A cells. Cancer Research, 44, 703 709.
11. Hori, T., Ayusawa, D., Glover, T.W. Seno, T. (1985) Expression of fragile site on the human X chromosome in somatic cell hybrids between human fragile X cells and thymidylate synthase-negative mouse mutant cells. Japanese Journal of Cancer Research, 76, 977 983.
12. Horie, N., Aiba, H., Oguro, K., Hojo, H. Takeishi, K. (1995) Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Structure and Function, 20, 191 197.
13. Jaffe, E.S., Harris, N.L., Stein, H. Vardiman, J.W. (eds 2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumors. IARC Press, Lyon
14. Kaneda, S., Takeishi, K., Ayusawa, D., Shimizu, K., Seno, T. Altman, S. (1987) Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA. Nucleic Acids Research, 15, 1259 1270.
15. Kawakami, K. Watanabe, G. (2003) Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Research, 63, 6004 6007.
16. Kawakami, K., Omura, K., Kanehira, E. Watanabe, Y. (1999) Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Research, 19, 3249 3252.
17. Leclerc, D., Campeau, E., Goyette, P., Adjalla, C.E., Christensen, B., Ross, M., Eydoux, P., Rosenblatt, D.S., Rozen, R. Gravel, R.A. (1996) Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Human Molecular Genetics, 5, 1867 1874.
18. Levine, A.J., Siegmund, K.D., Ervin, C.M., Diep, A., Lee, E.R., Frankl, H.D. Haile, R.W. (2000) The methylenetetrahydrofolate reductase 677C→T polymorphism and distal colorectal adenoma risk. Cancer Epidemiology, Biomarkers and Prevention, 9, 657 663.
19. Lightfoot, T.J., Skibola, C.F., Willett, E.V., Skibola, D.R., Allan, J.M., Coppede, F., Adamson, P.J., Morgan, G.J., Roman, E. Smith, M.T. (2005) Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiology, Biomarkers and Prevention, 14, 2999 3003.
20. Lim, U., Wang, S.S., Hartge, P., Cozen, W., Kelemen, L.E., Chanock, S., Davis, S., Blair, A., Schenk, M., Rothman, N. Lan, Q. (2007) Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood, 109, 3050 3059.
21. Lucock, M. (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Molecular Genetics and Metabolism, 71, 121 138.
22. Ma, J., Stampfer, M.J., Giovannucci, E., Artigas, C., Hunter, D.J., Fuchs, C., Willett, W.C., Selhub, J., Hennekens, C.H. Rozen, R. (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Research, 57, 1098 1102.
23. Ma, J., Stampfer, M.J., Christensen, B., Giovannucci, E., Hunter, D.J., Chen, J., Willett, W.C., Selhub, J., Hennekens, C.H., Gravel, R. Rozen, R. (1999) A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiology, Biomarkers and Prevention, 8, 825 829.
24. Mandola, M.V., Stoehlmacher, J., Muller-Weeks, S., Cesarone, G., Yu, M.C., Lenz, H.J. Ladner, R.D. (2003) A novel single nucleotide polymorphism within the 5′ tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Research, 63, 2898 2904.
25. Matsuo, K., Suzuki, R., Hamajima, N., Ogura, M., Kagami, Y., Taji, H., Kondoh, E., Maeda, S., Asakura, S., Kaba, S., Nakamura, S., Seto, M., Morishima, Y. Tajima, K. (2001) Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood, 97, 3205 3209.
26. Niclot, S., Pruvot, Q., Besson, C., Savoy, D., Macintyre, E., Salles, G., Brousse, N., Varet, B., Landais, P., Taupin, P., Junien, C. Baudry-Bluteau, D. (2006) Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood, 108, 278 285.
27. Olteanu, H., Munson, T. Banerjee, R. (2002) Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry, 41, 13378 13385.
28. Pullarkat, S.T., Stoehlmacher, J., Ghaderi, V., Xiong, Y.P., Ingles, S.A., Sherrod, A., Warren, R., Tsao-Wei, D., Groshen, S. Lenz, H.J. (2001) Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics Journal, 1, 65 70.
29. van der Put, N.M., Gabreels, F., Stevens, E.M., Smeitink, J.A., Trijbels, F.J., Eskes, T.K., van den Heuvel, L.P. Blom, H.J. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? American Journal of Human Genetics, 62, 1044 1051.
30. Skibola, C.F., Smith, M.T., Kane, E., Roman, E., Rollinson, S., Cartwright, R.A. Morgan, G. (1999) Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proceedings of the National Academy of Sciences of the United States of America, 96, 12810 12815.
31. Skibola, C.F., Smith, M.T., Hubbard, A., Shane, B., Roberts, A.C., Law, G.R., Rollinson, S., Roman, E., Cartwright, R.A. Morgan, G.J. (2002) Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood, 99, 3786 3791.
32. Skibola, C.F., Forrest, M.S., Coppede, F., Agana, L., Hubbard, A., Smith, M.T., Bracci, P.M. Holly, E.A. (2004) Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood, 104, 2155 2162.
33. Tan, W., Miao, X., Wang, L., Yu, C., Xiong, P., Liang, G., Sun, T., Zhou, Y., Zhang, X., Li, H. Lin, D. (2005) Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status. Carcinogenesis, 26, 1430 1435.
34. Ulrich, C.M., Kampman, E., Bigler, J., Schwartz, S.M., Chen, C., Bostick, R., Fosdick, L., Beresford, S.A., Yasui, Y. Potter, J.D. (1999) Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiology, Biomarkers and Prevention, 8, 659 668.
35. Ulrich, C.M., Bigler, J., Velicer, C.M., Greene, E.A., Farin, F.M. Potter, J.D. (2000) Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiology, Biomarkers and Prevention, 9, 1381 1385.
36. Ulrich, C.M., Bigler, J., Bostick, R., Fosdick, L. Potter, J.D. (2002) Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Research, 62, 3361 3364.
37. Wiemels, J.L., Smith, R.N., Taylor, G.M., Eden, O.B., Alexander, F.E. Greaves, M.F. (2001) Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proceedings of the National Academy of Sciences of the United States of America, 98, 4004 4009.
38. Zhang, G. Dai, C. (2001) Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thrombosis Research, 104, 187 195.
39. Zhang, J., Cui, Y., Kuang, G., Li, Y., Wang, N., Wang, R., Guo, W., Wen, D., Wei, L., Yu, F. Wang, S. (2004) Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Carcinogenesis, 25, 2479 2485.